---
title: "603334.SH (603334.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603334.SH/news.md"
symbol: "603334.SH"
name: "603334.SH"
parent: "https://longbridge.com/en/quote/603334.SH.md"
datetime: "2026-05-20T03:43:22.507Z"
locales:
  - [en](https://longbridge.com/en/quote/603334.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603334.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603334.SH/news.md)
---

# 603334.SH (603334.SH) — Related News

### [FENGBEI BIOTECH released its first-quarter performance, with a net profit attributable to the parent company of 40.88 million yuan, a year-on-year increase of 11.47%](https://longbridge.com/en/news/284417634.md)
*2026-04-28T15:43:02.000Z*
> FENGBEI BIOTECH released its Q1 2026 performance, with revenue of 1.109 billion yuan, a year-on-year increase of 66.55%;

### [FENGBEI BIOTECH: Net profit for the fiscal year 2025 is expected to be 141 million yuan, a year-on-year increase of 13.52%](https://longbridge.com/en/news/282193279.md)
*2026-04-09T12:17:08.000Z*
> FENGBEI BIOTECH announced that it achieved an operating revenue of 3.171 billion yuan in 2025, a year-on-year increase o

### [Suzhou FENGBEI BIOTECH: The cumulative deviation value of the stock's increase over 2 consecutive days exceeds 20%](https://longbridge.com/en/news/274944970.md)
*2026-02-05T09:12:39.000Z*
> Suzhou FENGBEI BIOTECH announced that the company's stock price deviation exceeded 20% cumulatively over two consecutive

### [Heyuan Biotechnology: Expected net loss of 143 million to 167 million yuan in 2025](https://longbridge.com/en/news/273954920.md)
*2026-01-28T08:10:01.000Z*
> Heyuan Bio is expected to incur a net loss of 143 million to 167 million yuan in 2025, despite rapid growth in sales rev

### [Dayu Biotechnology: Expected loss of 26 million to 30 million yuan in 2025](https://longbridge.com/en/news/273680247.md)
*2026-01-26T09:36:34.000Z*
> Dayu Bio announced that it expects a negative annual net profit for 2025, with a projected loss of between 30 million yu

### [JD HEALTH and Pinnacle Bio have reached a cooperation on integrated health management solutions](https://longbridge.com/en/news/273188534.md)
*2026-01-21T07:11:09.000Z*
> JD HEALTH has reached a deep cooperation with Beijing Dingfeng Biotechnology to jointly create an integrated health mana

### [Dragon and Tiger List | FENGBEI BIOTECH rose by 2.57%, with well-known speculative funds buying 20.6398 million yuan in Century Avenue, Pudong New District, Shanghai](https://longbridge.com/en/news/265492783.md)
*2025-11-12T10:31:01.000Z*
> FENGBEI BIOTECH rose 2.57% on November 12, with a daily turnover rate of 20%, making it to the leaderboard. Notable spec

### [3 companies went public in 3 days! The "Suzhou sector" is rapidly expanding](https://longbridge.com/en/news/264887680.md)
*2025-11-07T13:45:32.000Z*
> On November 7th, Zhongcheng Zhixin Engineering Consulting Group Co., Ltd. was listed on the Beijing Stock Exchange. In a

### [Seizing the "Waste Oil Utilization" trillion-yuan track, the rise of biobased industries behind FENGBEI BIOTECH's IPO](https://longbridge.com/en/news/264811591.md)
*2025-11-07T08:34:59.000Z*
> FENGBEI BIOTECH is conducting an IPO, planning to raise 750 million yuan for capacity expansion to address capacity bott